AFP and neoplasm: Recurrence after LT can be estimated by the Risk Estimation of Tumour Recurrence After Transplant (RETREAT) score, which holds significant value in guiding post-LT surveillance and treatment by utilising pre-transplant alpha-fetoprotein (AFP) levels and pathological explant data [8].